uk-dgm MCQ (SBA): SGLT2 Inhibitor for CKD Protection in Diabetes

Instant feedback + full explanation. One question, done properly.

HardMultimorbidity & Long-term ConditionsSGLT2 Inhibitor for CKD Protection in Diabetesuk-dgm

A 69-year-old man has been recently diagnosed with chronic kidney disease stage 3b (eGFR 35 mL/min/1.73m²), type 2 diabetes, and hypertension. He is on Metformin 1 g BD, Ramipril 10 mg, and Amlodipine 10 mg. His blood pressure is 142/88 mmHg. HbA1c is 56 mmol/mol. Urine albumin:creatinine ratio (ACR) is 45 mg/mmol. According to current guidelines, what additional medication should be considered?

Educational content. Not a substitute for clinical judgement or local policy.

uk-dgm MCQ: SGLT2 Inhibitor for CKD Protection in Diabetes — Answer &